{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06186388",
            "orgStudyIdInfo": {
                "id": "CF-2023-01"
            },
            "organization": {
                "fullName": "Cape Fear Eye Institute",
                "class": "OTHER"
            },
            "briefTitle": "Glaucoma Screening",
            "officialTitle": "TEMPO (iMOvifa) Glaucoma Screening",
            "therapeuticArea": [
                "Ophthalmology"
            ],
            "study": "glaucoma-screening"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-05",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-04-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-04-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-12-15",
            "studyFirstSubmitQcDate": "2023-12-15",
            "studyFirstPostDateStruct": {
                "date": "2024-01-02",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-12-15",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-02",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Cape Fear Eye Institute",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "* The primary objective of this study is to evaluate the diagnostic accuracy of the TEMPO (iMOvifa) visual field perimeter screening test by measuring the sensitivity in a population of eyes with glaucoma and the specificity in a population of normal eyes and to measure repeatability of the screening test.\n* The secondary objective of this study is to gather and analyze ancillary data to confirm the diagnosis or absence of glaucoma."
        },
        "conditionsModule": {
            "conditions": [
                "Glaucoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 200,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Pathology",
                    "type": "OTHER",
                    "description": "Subjects with glaucoma-affected eyes",
                    "interventionNames": [
                        "Diagnostic Test: TEMPO iMOvifa"
                    ]
                },
                {
                    "label": "Normal",
                    "type": "OTHER",
                    "description": "Subjects with healthy eyes",
                    "interventionNames": [
                        "Diagnostic Test: TEMPO iMOvifa"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "TEMPO iMOvifa",
                    "description": "Screening test with 28 testing points",
                    "armGroupLabels": [
                        "Normal",
                        "Pathology"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Sensitivity and specificity",
                    "description": "sensitivity in a population of eyes with glaucoma and specificity in a population of normal eyes",
                    "timeFrame": "1 day"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "RNFL and GCL thickness",
                    "description": "Using Maestro2 OCT",
                    "timeFrame": "1 day"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria (All subjects):\n\n* Subjects 40 years of age or older on the date of informed consent.\n* Subjects able to understand the written informed consent and willing to participate as evidenced by signing the informed consent.\n* BCVA 20/40 or better in both eyes.\n\nInclusion Criteria- Normal Population\n\n* IOP \u2264 21 mmHg\n* Healthy anterior and posterior segment evaluation on clinical examination.\n\nInclusion Criteria - Pathology Population\n\n\u2022 Diagnosis of glaucoma on clinical examination.\n\nExclusion Criteria (All subjects):\n\n* Unable to tolerate ophthalmic imaging and/or diagnostic testing.\n* History of intraocular surgery (uncomplicated surgeries are accepted).\n* Ocular diseases including uveitis, non-glaucomatous optic neuropathy, severe or proliferative diabetic/ hypertensive retinopathy (controlled diabetes and hypertension participants with no or mild to moderate retinopathy \\[not involving the macula\\] can be included), unresolved trauma.\n* Any neurodegenerative diseases including Alzheimer, Parkinson, or dementia, or history of stroke.\n* Unreliable VF testing and/or poor-quality OCT scans.\n* Poor fixation.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "40 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "James Fanelli, OD",
                    "role": "CONTACT",
                    "phone": "910-452-7225",
                    "email": "faneleye@aol.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Christina Jones",
                    "affiliation": "Clinical Research Coordinator",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Cape Fear Eye Institute",
                    "status": "RECRUITING",
                    "city": "Wilmington",
                    "state": "North Carolina",
                    "zip": "28412",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "James Fanelli, OD",
                            "role": "CONTACT",
                            "phone": "910-452-7225",
                            "email": "faneleye@aol.com"
                        },
                        {
                            "name": "Christina Jones",
                            "role": "CONTACT",
                            "phone": "910-452-7225",
                            "email": "cfortejones@rocketmail.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.22573,
                        "lon": -77.94471
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005901",
                    "term": "Glaucoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009798",
                    "term": "Ocular Hypertension"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9013",
                    "name": "Glaucoma",
                    "asFound": "Glaucoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10024",
                    "name": "Hypertension",
                    "relevance": "LOW"
                },
                {
                    "id": "M12731",
                    "name": "Ocular Hypertension",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000003959",
                    "term": "TEMPO"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000975",
                    "term": "Antioxidants"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000020011",
                    "term": "Protective Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M251057",
                    "name": "TEMPO",
                    "asFound": "Small Cell Lung Cancer (SCLC)",
                    "relevance": "HIGH"
                },
                {
                    "id": "M186190",
                    "name": "Aluminum hydroxide, magnesium hydroxide, simethicone drug combination",
                    "relevance": "LOW"
                },
                {
                    "id": "M4292",
                    "name": "Antioxidants",
                    "relevance": "LOW"
                },
                {
                    "id": "M21869",
                    "name": "Protective Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                }
            ]
        }
    },
    "hasResults": false
}